Cite
Efficacy of Combination Therapy with Linalool and Doxorubicin Encapsulated by Liposomes as a Two-in-One Hybrid Carrier System for Epithelial Ovarian Carcinoma
MLA
Jeong-Won Lee, et al. “Efficacy of Combination Therapy with Linalool and Doxorubicin Encapsulated by Liposomes as a Two-in-One Hybrid Carrier System for Epithelial Ovarian Carcinoma.” International Journal of Nanomedicine, Oct. 2020. EBSCOhost, widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsair&AN=edsair.doi.dedup.....c6adb0a1969ff4d2012ba46c8899dbe4&authtype=sso&custid=ns315887.
APA
Jeong-Won Lee, Chan Mi Lee, Tae In Wi, Ji Eun Won, Hee Dong Han, Yeong-Min Park, Tae Heung Kang, & Byung Cheol Shin. (2020). Efficacy of Combination Therapy with Linalool and Doxorubicin Encapsulated by Liposomes as a Two-in-One Hybrid Carrier System for Epithelial Ovarian Carcinoma. International Journal of Nanomedicine.
Chicago
Jeong-Won Lee, Chan Mi Lee, Tae In Wi, Ji Eun Won, Hee Dong Han, Yeong-Min Park, Tae Heung Kang, and Byung Cheol Shin. 2020. “Efficacy of Combination Therapy with Linalool and Doxorubicin Encapsulated by Liposomes as a Two-in-One Hybrid Carrier System for Epithelial Ovarian Carcinoma.” International Journal of Nanomedicine, October. http://widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsair&AN=edsair.doi.dedup.....c6adb0a1969ff4d2012ba46c8899dbe4&authtype=sso&custid=ns315887.